EUVIMEDEUVIMED entdecken
Crossref

Cationic Fullerenes for Efficient siRNA Delivery to Pancreatic Cancer

Maciej Serda, Dominik Dreszer, Katarzyna Malarz, Robert Gawecki, Magdalena Szubka, Sylwia Bobis-Wozowicz, Antonietta Greco, Claudia Corbo

ECS Meeting Abstracts · 07.07.2026 · MA2026-01 (9) · 817-817

DOI: 10.1149/ma2026-019817mtgabs ↗

Kurz gefasst

Fachartikel in der Zeitschrift ECS Meeting Abstracts, erschienen am 07.07.2026. Verfasst von Maciej Serda und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Small interfering RNA (siRNA) constitutes a potent strategy for selectively suppressing genes implicated in cancer progression through the RNA interference (RNAi) pathway. However, unmodified (“naked”) siRNA is highly susceptible to nuclease-mediated degradation in biological fluids and exhibits poor cellular internalization because of its relatively large size and polyanionic character, which limits membrane permeation. Consequently, nanomaterial-based delivery systems—particularly those employing carbon nanomaterials—have gained attention as non-viral carriers capable of protecting siRNA from degradation, improving cellular uptake, and facilitating targeted delivery. To enhance biocompatibility and colloidal stability, carbon nanomaterials are frequently functionalized to increase aqueous dispersibility and tune surface charge (zeta potential), thereby promoting the formation of stable complexes with negatively charged nucleic acids. Nonetheless, existing siRNA delivery platforms, including chemically modified siRNA formulations and viral vector–based systems, remain constrained by substantial limitations such as immunogenicity, limited cargo capacity, challenges associated with scalable manufacturing, and suboptimal gene-silencing performance. Here, we report the synthesis of two distinct fullerene-based nanomaterials built on C 60 and C 70 scaffolds for efficient siRNA delivery in pancreatic cancer gene therapy. Physicochemical analyses confirmed the colloidal stability of the resulting nanomaterials and their net positive zeta potentials. Cytotoxicity assays performed in pancreatic cancer cell lines indicated minimal toxicity of these nanoscale transfection agents. Using modified GFP-expressing PANC-1 cells, we subsequently demonstrated high siRNA transfection efficiency together with an absence of detectable cytotoxicity across the evaluated concentration range. Additional cellular studies further supported the translational promise of these fullerene platforms, showing suppression of KRAS and EGFR protein expression in PANC-1 cells, alongside no observable toxicity in an in vivo zebrafish model. Finally, advanced proteomic profiling provided an in-depth comparison of the protein corona compositions formed on the cationic fullerenes, including their siRNA-loaded complexes. Funding: This studies were funded by National Science Center Poland (2019/35/B/NZ7/02459) awarded to prof. Maciej Serda.

Zitieren

APA

Serda, M., Dreszer, D., Malarz, K., Gawecki, R., Szubka, M., Bobis-Wozowicz, S., Greco, A., & Corbo, C. (2026). Cationic Fullerenes for Efficient siRNA Delivery to Pancreatic Cancer. ECS Meeting Abstracts, MA2026-01(9), 817-817. https://doi.org/10.1149/ma2026-019817mtgabs

Vancouver

Serda M, Dreszer D, Malarz K, Gawecki R, Szubka M, Bobis-Wozowicz S, et al. Cationic Fullerenes for Efficient siRNA Delivery to Pancreatic Cancer. ECS Meeting Abstracts. 2026;MA2026-01(9):817-817. doi:10.1149/ma2026-019817mtgabs

BibTeX
@article{Serda2026,
  author = {Serda, Maciej and Dreszer, Dominik and Malarz, Katarzyna and Gawecki, Robert and Szubka, Magdalena and Bobis-Wozowicz, Sylwia and Greco, Antonietta and Corbo, Claudia},
  title = {Cationic Fullerenes for Efficient siRNA Delivery to Pancreatic Cancer},
  journal = {ECS Meeting Abstracts},
  year = {2026},
  volume = {MA2026-01},
  number = {9},
  pages = {817--817},
  doi = {10.1149/ma2026-019817mtgabs}
}
Kostenlos starten →